News
EQS-Adhoc: New Work SE: Executive Board decides on investment program and Group restructuring | Outlook for 2024 | Dividend and medium to long-term financial targets
EQS-Adhoc: New Work SE: Executive Board decides on investment program and Group restructuring | Outlook for 2024 | Dividend and medium to long-term financial targets
EQS-News: ABOUT YOU: All-time High EBITDA and Free Cash Flow despite Targeted Investments in Customer Experience and Brand Awareness
EQS-News: ABOUT YOU: All-time High EBITDA and Free Cash Flow despite Targeted Investments in Customer Experience and Brand Awareness
EQS-Adhoc: HENSOLDT AG: HENSOLDT successfully completes cash capital increase through accelerated bookbuilding
EQS-Adhoc: HENSOLDT AG: HENSOLDT successfully completes cash capital increase through accelerated bookbuilding
EQS-Adhoc: HENSOLDT AG: HENSOLDT launches cash capital increase through accelerated bookbuilding
EQS-Adhoc: HENSOLDT AG: HENSOLDT launches cash capital increase through accelerated bookbuilding
EQS-News: HENSOLDT acquires ESG Elektroniksystem- und Logistik-GmbH
EQS-News: HENSOLDT acquires ESG Elektroniksystem- und Logistik-GmbH
EQS-Adhoc: HENSOLDT acquires ESG Elektroniksystem- und Logistik GmbH
EQS-Adhoc: HENSOLDT acquires ESG Elektroniksystem- und Logistik GmbH
EQS-News: HENSOLDT is on track for a strong 2023 financial year and confirms medium-term targets
EQS-News: HENSOLDT is on track for a strong 2023 financial year and confirms medium-term targets
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-Adhoc: HENSOLDT AG: HENSOLDT AG confirms preparations of a potential capital increase
EQS-Adhoc: HENSOLDT AG: HENSOLDT AG confirms preparations of a potential capital increase
EQS-News: HENSOLDT continues growth trajectory with significant revenue growth in core business in the third quarter of 2023
EQS-News: HENSOLDT continues growth trajectory with significant revenue growth in core business in the third quarter of 2023
EQS-News: Instone continues its very solid performance in a still challenging environment; outlook for 2023 confirmed
EQS-News: Instone continues its very solid performance in a still challenging environment; outlook for 2023 confirmed
EQS-News: New Work SE: Recruiting business grows by 7 per cent in first nine months of 2023 amid difficult market environment
EQS-News: New Work SE: Recruiting business grows by 7 per cent in first nine months of 2023 amid difficult market environment
EQS-News: Continued strong performance in the third quarter of 2023
EQS-News: Continued strong performance in the third quarter of 2023
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-News: SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven
EQS-News: SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Higher Profit Margin and Strong Cash Flow
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Sees Higher Profit Margin and Strong Cash Flow
EQS-News: TRATON GROUP raises forecast for full-year 2023 following successful business performance in the first nine months
EQS-News: TRATON GROUP raises forecast for full-year 2023 following successful business performance in the first nine months
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
EQS-News: ABOUT YOU Holding SE: ABOUT YOU on Track: Accelerated Growth and Significant Margin Improvement
EQS-News: ABOUT YOU Holding SE: ABOUT YOU on Track: Accelerated Growth and Significant Margin Improvement
EQS-News: SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven
EQS-News: SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven
EQS-Adhoc: SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement
EQS-Adhoc: SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement
EQS-News: Knorr-Bremse Aktiengesellschaft: Dr. Nicolas Lange to join Knorr-Bremse’s Executive Board and guide the market leader’s rail business
EQS-News: Knorr-Bremse Aktiengesellschaft: Dr. Nicolas Lange to join Knorr-Bremse’s Executive Board and guide the market leader’s rail business
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment